Compositions comprising ADDL receptor syngap

Details for Australian Patent Application No. 2005244013 (hide)

Owner Northwestern University Acumen Pharmaceuticals

Inventors Velasco, Pauline T.; Lowe, Ray; Catalano, Susan; Pray, Todd; Chang, Lei; Krafft, Grant A.; Klein, William L.; Buniel, Maria C.; Fernandez, Sara J.; Gong, Yuesong; Lambert, Mary P.; Jerecic, Jasna; Bigio, Eileen H.; Lacor, Pascale N.; Viola, Kirsten L.

Agent Freehills

Pub. Number AU-A-2005244013

PCT Pub. Number WO2005/110056

Priority 60/636,466 15.12.04 US; 60/571,267 14.05.04 US

Filing date 16 May 2005

Wipo publication date 24 November 2005

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/110056 Priority application(s): WO2005/110056

20 September 2007 Change of Name(s) of Applicant(s), Section 104

  Northwestern University; Acumen Pharmaceuticals The name of the applicant has been changed to Northwestern University; Acumen Pharmaceuticals, Inc.

12 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244022-Molasses treatment for the "molassperse" surfactant production for concrete plasticizers (water reducing admixtures) and cement clinker grinding additives applications

2005244012-Prolongation of survival of an allograft by inhibiting complement activity